Home
About Us
News
Product Technology
Contact & Investor Information
News
Xenogenics Corporation Retains the Emmes Group to Advise on Fund Raising Efforts February 23, 2011
MultiCell's Majority Owned Subsidiary Acquires Bioabsorbable Interventional Cardiology Stent Assets, October 19, 2010
© 2011 Xenogenics Corporation